Many Bright Ideas Technologies Inc. (TSXV: MBI-H) Stock Analysis & Fundamentals | ScreenerHero

Create free account

MBI-HMany Bright Ideas Technologies Inc.

TSXV · CA · Healthcare · Diagnostics & Research · medbiogene.com

0.0300CAD0.00%Mkt Cap: 314205 $P/E: Infinity2d ago

Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was involved in the life science business with a focus on the commercialization of prognostic genomic-based tests for non-…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.26BUSDP/E 43.7

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.21BUSDP/E 27.6

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.40BUSDP/E 22.0

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.73BUSDP/E 26.3

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.70BUSDP/E 43.3

GeneDx Holdings Corp.

Personalis, Inc.

Diagnostyka S.A.

$1.46BUSDP/E 22.1

Clínica Baviera, S.A.

$996.45MUSDP/E 20.9

OPKO Health, Inc.

Castle Biosciences, Inc.

$653.57MUSDP/E 42.6

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$292.59MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap314.20K $

Enterprise Value451.73K $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-33.86K $

Revenue/Share—

Last Price0.0300 CAD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees—

CountryCA

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)Infinity

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-1.38

EPS (TTM)0.00

EPS (Forward)—

52W Range

0.020033% of range0.0500

52W High0.0500 CAD

52W Low0.0200 CAD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE20.75%

ROA-2088.63%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-32.23K $

CapEx (TTM)—

FCF Margin—

FCF Yield-37.60%

Net Debt137.53K $

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio0.04

Quick Ratio0.00

Book Value/Sh-0.0181 CAD

Cash/Share0.0000 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateDec 19, 2017

Splits

Last Split1:10

Split DateDec 19, 2017

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.17.26M

Float16.94M

Insiders49.22%

Institutions0.00%

Short Interest

Short % Out.0.00%

Shares Short403

Short (prev mo.)403

Technical

SMA 500.0296 (+1.4%)

SMA 2000.0259 (+16.1%)

Beta1.57

S&P 52W Chg19.63%

Avg Vol (30d)0

Avg Vol (10d)0

Technical Indicators

RSI (14)99.9

MACD0.0003

MACD Signal0.0004

MACD Hist.-0.0001

BB Upper0.0300 CAD

BB Middle0.0300 CAD

BB Lower0.0300 CAD

BB Width0.00%

ATR (14)0.0000 CAD

Vol Ratio (20d)—